Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D03ZOR
|
|||
Drug Name |
Epoxysuccinate derivative 9
|
|||
Synonyms |
PMID25399719-Compound-26
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
|
|||
Structure |
Download2D MOL |
|||
Formula |
C19H16FN5O5S
|
|||
Canonical SMILES |
C1=CC(=CC=C1C2=CSC(=N2)NC(=O)C(CC3=CN=CN3)NC(=O)C4C(O4)C(=O)O)F
|
|||
InChI |
1S/C19H16FN5O5S/c20-10-3-1-9(2-4-10)13-7-31-19(24-13)25-16(26)12(5-11-6-21-8-22-11)23-17(27)14-15(30-14)18(28)29/h1-4,6-8,12,14-15H,5H2,(H,21,22)(H,23,27)(H,28,29)(H,24,25,26)/t12-,14+,15+/m0/s1
|
|||
InChIKey |
LWEKDSQGUMPMSP-NWANDNLSSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Calpain-2 (CAPN2) | Target Info | Inhibitor | [1] |
Target's Patent Info | Calpain-2 (CAPN2) | Target's Patent Info | [1] | |
KEGG Pathway | Protein processing in endoplasmic reticulum | |||
Apoptosis | ||||
Alzheimer's disease | ||||
Reactome | Degradation of the extracellular matrix | |||
WikiPathways | Focal Adhesion | |||
Integrated Pancreatic Cancer Pathway | ||||
Alzheimers Disease | ||||
Integrin-mediated Cell Adhesion |
References | Top | |||
---|---|---|---|---|
REF 1 | An updated patent review of calpain inhibitors (2012 - 2014).Expert Opin Ther Pat. 2015 Jan;25(1):17-31. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.